Alzheimer's Disease Genetics Study
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorIndiana University
About this trial
The purpose of the Alzheimer's Disease Genetics Study is to identify the genes that are responsible for causing Alzheimer's Disease (AD). One of the ways in which the risk factor genes for late onset AD can be investigated is by identifying and collecting genetic material from families with multiple members diagnosed with AD or dementia.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Two living family members diagnosed with AD or other dementia with any age of onset
Biological samples available
Fresh blood, or
Immortalized lymphoblastic cell lines, or
Disqualifiers
Does not meet inclusion criteria
Member of a family that was included in the National Institute of Mental Health AD Genetics Sib Pair collection
Trial population
Families with two or more members with Alzheimer's disease or dementia
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
No trial groups listed
Trial outcomes
Primary outcomes
1
Distribute biological specimens to qualified investigators for use in their research studies.
Investigators will analyze the samples and publish de-identified results. These publications will help to further the knowledge in the field of dementia and potentially lead to new therapies and targets for therapies.
Time frame
Contact investigators annually for an update on progress and publication status.Locations
1Map coordinates are unavailable for these locations. Locations are shown below instead.
Participants are being recruited from all over the United StatesRecruiting46202, Nationwide, Indiana
United States
United StatesSponsors and contacts
Click on the lead sponsor to view all of their trials.
Indiana University
Lead sponsor
National Institute on Aging (NIA)
Collaborator
Source ClinicalTrials.gov